In this Issue:
Empagliflozin + linagliptin in untreated type 2 diabetes
Energy balance following SGLT-2 inhibition
Pollutants and type 2 diabetes
Hyaluronidase pretreatment of insulin cannula sites in type 1 diabetes
Saxagliptin in patients with prior HF
Predicting success of exenatide twice daily
ADVANCE-ON: post-trial observations
Adherence to oral antihyperglycaemic monotherapy in type 2 diabetes
Differentiating between types 1 and 2 diabetes
Diabetes is not a CAD risk equivalent in women
Please login below to download this issue (PDF)